← Back to Screener
Cryo-Cell International Inc. (CCEL)
Price$3.56
Favorite Metrics
Price vs S&P 500 (26W)-31.01%
Price vs S&P 500 (4W)0.76%
Market Capitalization$27.71M
P/E Ratio (Annual)69.51x
Indicated Dividend Yield (Annual)11.63%
All Metrics
P/CF (Annual)5.06x
Book Value / Share (Quarterly)$0.52
P/TBV (Annual)40.23x
Revenue Growth (3Y)1.33%
Cash Flow / Share (Quarterly)$0.77
Price vs S&P 500 (YTD)-4.14%
Gross Margin (TTM)76.63%
Net Profit Margin (TTM)-7.70%
EPS (TTM)$-0.30
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-0.30
Revenue Growth (5Y)0.27%
EPS (Annual)$-0.30
Dividend / Share (Annual)$0.40
ROI (Annual)34.26%
Gross Margin (Annual)76.63%
Net Profit Margin (5Y Avg)-4.09%
Cash / Share (Quarterly)$0.41
Revenue Growth QoQ (YoY)-2.26%
EPS Growth (5Y)-29.04%
P/E Normalized (Annual)69.51x
ROA (Last FY)-3.94%
Revenue Growth TTM (YoY)-1.31%
EBITD / Share (TTM)$0.16
ROE (5Y Avg)48.39%
Operating Margin (TTM)1.53%
Cash Flow / Share (Annual)$0.65
P/B Ratio6.29x
P/B Ratio (Quarterly)10.59x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.13x
Net Interest Coverage (TTM)0.19x
ROA (TTM)-3.83%
EPS Growth QoQ (YoY)-27.89%
EV / EBITDA (TTM)27.78x
EPS Incl Extra (Annual)$-0.30
Current Ratio (Annual)0.59x
Quick Ratio (Quarterly)0.54x
3-Month Avg Trading Volume0.01M
52-Week Price Return-42.95%
EV / Free Cash Flow (Annual)6.81x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.34
P/S Ratio (Annual)0.88x
Asset Turnover (Annual)0.51x
52-Week High$6.35
Operating Margin (5Y Avg)0.07%
EPS Excl Extra (Annual)$-0.30
CapEx CAGR (5Y)18.18%
26-Week Price Return-22.27%
Quick Ratio (Annual)0.54x
13-Week Price Return1.47%
Total Debt / Equity (Annual)0.45x
Current Ratio (Quarterly)0.59x
Enterprise Value$35.745
Revenue / Share Growth (5Y)0.44%
Asset Turnover (TTM)0.50x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)13.83x
Pretax Margin (Annual)-7.40%
Cash / Share (Annual)$0.41
3-Month Return Std Dev44.84%
Gross Margin (5Y Avg)72.95%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)-28.23%
EBITDA Interim CAGR (5Y)7.70%
ROE (Last FY)49.79%
Net Interest Coverage (Annual)0.19x
EPS Basic Excl Extra (Annual)$-0.30
P/FCF (TTM)4.48x
Receivables Turnover (TTM)4.46x
EV / Free Cash Flow (TTM)5.78x
Total Debt / Equity (Quarterly)0.08x
EPS Incl Extra (TTM)$-0.30
Receivables Turnover (Annual)4.46x
ROI (TTM)28.47%
P/S Ratio (TTM)0.88x
Pretax Margin (5Y Avg)-4.26%
Revenue / Share (Annual)$3.91
Tangible BV / Share (Annual)$0.31
Forward P/E32.36x
Free OCF CAGR (5Y)-8.91%
Price vs S&P 500 (52W)-78.05%
Year-to-Date Return0.00%
5-Day Price Return-4.44%
EPS Normalized (Annual)$-0.30
ROA (5Y Avg)-2.23%
Net Profit Margin (Annual)-7.70%
Month-to-Date Return-3.10%
Cash Flow / Share (TTM)$0.47
EBITD / Share (Annual)$0.16
EPS Growth (3Y)-41.85%
Operating Margin (Annual)1.53%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)4.36x
ROI (5Y Avg)45.26%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.30
P/TBV (Quarterly)16.12x
Payout Ratio (Annual)502.50%
P/B Ratio (Annual)25.24x
Dividend / Share (TTM)$0.65
Inventory Turnover (TTM)13.83x
Pretax Margin (TTM)-7.40%
Book Value / Share (Annual)$0.49
Price vs S&P 500 (13W)-1.39%
Net Margin Growth (5Y)-29.43%
Dividend Yield (TTM)18.95%
Beta0.61x
P/FCF (Annual)5.28x
Revenue / Share (TTM)$3.92
ROE (TTM)38.23%
52-Week Low$2.72
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.17
2.17
2.17
2.17
Industry Peers — Health Services(14)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
CCELCryo-Cell International Inc. | 69.51x | -1.31% | 1.53% | 38.23% | $3.56 |
FMSFresenius Medical Care AG | 11.75x | 1.51% | 9.31% | 7.26% | $23.18 |
DVADaVita Inc. | 13.37x | 6.46% | 14.88% | 181.22% | $149.33 |
SHCSotera Health Company Common Stock | 59.47x | 5.74% | 25.41% | 14.98% | $16.28 |
PGNYProgyny, Inc. Common Stock | 24.25x | 10.40% | 6.62% | 11.37% | $18.64 |
AGLagilon health, inc. | — | -2.11% | -7.81% | -116.65% | $28.30 |
MCTACharming Medical Limited Class A Ordinary Shares | 414.66x | — | 15.45% | — | $29.36 |
VMDViemed Healthcare, Inc. Common Shares | 24.97x | 20.52% | 8.49% | 10.87% | $9.66 |
QIPTQuipt Home Medical Corp. Ordinary Shares | — | 9.52% | -1.22% | -10.47% | $3.65 |
PARKPark Dental Partners, Inc. Common Stock | 17.91x | — | 0.10% | — | $18.25 |
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares | 174.54x | — | — | -0.64% | $12.20 |
About
Cryo-Cell International Inc specializes in the collection, processing, and cryogenic storage of umbilical cord blood and tissue stem cells for both private family banking and public banking applications. The company operates through three segments: private cellular banking services, public cord blood banking, and its PrepaCyte CB processing technology platform. Revenue is generated from processing fees, testing services, and long-term cryogenic storage.